These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
655 related articles for article (PubMed ID: 28958756)
1. Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease. Spinthakis N; Farag M; Gorog DA; Prasad A; Mahmood H; Gue Y; Wellsted D; Nabhan A; Srinivasan M Int J Cardiol; 2017 Dec; 249():101-106. PubMed ID: 28958756 [TBL] [Abstract][Full Text] [Related]
2. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW; Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960 [TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215 [TBL] [Abstract][Full Text] [Related]
5. A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Disease. Kodumuri V; Balasubramanian S; Vij A; Siddamsetti S; Sethi A; Khalafallah R; Khosla S Am J Cardiol; 2018 Apr; 121(8):924-933. PubMed ID: 29502793 [TBL] [Abstract][Full Text] [Related]
6. Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis. Zhang J; Jiang T; Hou Y; Chen F; Yang K; Sang W; Wu H; Ma Y; Xu F; Chen Y Atherosclerosis; 2020 Sep; 308():50-56. PubMed ID: 32713512 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis. Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214 [TBL] [Abstract][Full Text] [Related]
10. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting. Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112 [TBL] [Abstract][Full Text] [Related]
11. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ; Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014 [TBL] [Abstract][Full Text] [Related]
12. Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials. Putzu A; Gallo M; Martino EA; Ferrari E; Pedrazzini G; Moccetti T; Cassina T Int J Cardiol; 2017 Aug; 241():142-148. PubMed ID: 28438354 [TBL] [Abstract][Full Text] [Related]
13. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706 [TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stent placement versus coronary artery bypass surgery for unprotected left main coronary artery disease: A meta-analysis of randomized controlled trials. Upadhaya S; Baniya R; Madala S; Subedi SK; Khan J; Velagapudi RK; Bachuwa G J Card Surg; 2017 Feb; 32(2):70-79. PubMed ID: 28081585 [TBL] [Abstract][Full Text] [Related]
15. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes. Milojevic M; Serruys PW; Sabik JF; Kandzari DE; Schampaert E; van Boven AJ; Horkay F; Ungi I; Mansour S; Banning AP; Taggart DP; Sabaté M; Gershlick AH; Bochenek A; Pomar J; Lembo NJ; Noiseux N; Puskas JD; Crowley A; Kosmidou I; Mehran R; Ben-Yehuda O; Généreux P; Pocock SJ; Simonton CA; Stone GW; Kappetein AP J Am Coll Cardiol; 2019 Apr; 73(13):1616-1628. PubMed ID: 30947913 [TBL] [Abstract][Full Text] [Related]
16. Stent versus Coronary Artery Bypass Surgery in Multi-Vessel and Left Main Coronary Artery Disease: A Meta-Analysis of Randomized Trials with Subgroups Evaluation. Andrade PJN; Falcão JLAA; Falcão BAA; Rocha HAL Arq Bras Cardiol; 2019 May; 112(5):511-523. PubMed ID: 30810609 [TBL] [Abstract][Full Text] [Related]
17. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials. Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779 [TBL] [Abstract][Full Text] [Related]
18. Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated systematic review and meta-analysis. Ariyaratne TV; Ademi Z; Yap CH; Billah B; Rosenfeldt F; Yan BP; Reid CM Int J Cardiol; 2014 Sep; 176(2):346-53. PubMed ID: 25127976 [TBL] [Abstract][Full Text] [Related]
19. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II. Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW; Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761 [TBL] [Abstract][Full Text] [Related]
20. Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials. Ahmad Y; Howard JP; Arnold AD; Cook CM; Prasad M; Ali ZA; Parikh MA; Kosmidou I; Francis DP; Moses JW; Leon MB; Kirtane AJ; Stone GW; Karmpaliotis D Eur Heart J; 2020 Sep; 41(34):3228-3235. PubMed ID: 32118272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]